BOLLI, NICCOLO'
BOLLI, NICCOLO'
Dipartimento di Oncologia ed Emato-Oncologia
Whole-exome sequencing is feasible on a fresh-frozen skin sample of intravascular large B cell lymphoma
2024 F. Bagnoli, G. Pini, B. Ziccheddu, A. Bonometti, S. Alberti-Violetti, L. Venegoni, G. Isimbaldi, M.C. Da Vià, A. Ferrari, L. Baldini, A. Neri, F. Onida, N. Bolli, E. Berti
The pleiotropic nature of NONO, a master regulator of essential biological pathways in cancers
2024 D. Ronchetti, V. Traini, I. Silvestris, G. Fabbiano, F. Passamonti, N. Bolli, E. Taiana
Value and limitations of targeted next-generation sequencing in idiopathic hypereosinophilia: an integrative diagnostic tool in challenging cases
2024 D. Cattaneo, A. Marchetti, C. Bucelli, N. Galli, M. Lionetti, V. Bellani, U. Gianelli, F. Passamonti, N. Bolli, A. Iurlo
Circulating biomarkers in familial cerebral cavernous malformation
2024 F. Lazzaroni, J.M.T.A. Meessen, Y. Sun, S. Lanfranconi, E. Scola, Q.G. D'Alessandris, L. Tassi, M.R. Carriero, M. Castori, S. Marino, A. Blanda, E.B. Nicolis, D. Novelli, R. Calabrese, N.M. Agnelli, B. Bottazzi, R. Leone, S. Mazzola, S. Besana, C. Catozzi, L. Nezi, M.G. Lampugnani, M. Malinverno, N. Grdseloff, C.J. Rödel, B. Rezai Jahromi, N. Bolli, F. Passamonti, P.U. Magnusson, S. Abdelilah-Seyfried, E. Dejana, R. Latini
ZEB1 shapes AML immunological niches, suppressing CD8 T cell activity while fostering Th17 cell expansion
2024 B. Bassani, G. Simonetti, V. Cancila, A. Fiorino, M. Ciciarello, A. Piva, A.M. Khorasani, C. Chiodoni, D. Lecis, A. Gulino, E. Fonzi, L. Botti, P. Portararo, M. Costanza, M. Brambilla, G. Colombo, J. Schwaller, A. Tzankov, M. Ponzoni, F. Ciceri, N. Bolli, A. Curti, C. Tripodo, M.P. Colombo, S. Sangaletti
Comparison between indolent systemic mastocytosis and clonal mast cell disease not meeting WHO diagnostic criteria: A nationwide multicenter retrospective analysis
2024 M. Sciumè, F. Serpenti, R. Zanotti, P. Bonadonna, I. Tanasi, L. Crosera, C. Elena, F. Mannelli, F. Crupi, C. Papayannidis, C. Sartor, S. Soverini, M. Rondoni, C. Eller-Vainicher, V. Pravettoni, F. Rivolta, S. Alberti Violetti, G.A. Croci, A.C. Migliorini, N. Bolli, D. Giannarelli, F.I. Grifoni
Clonal Hematopoiesis of Indeterminate Potential in Patients with Immunoglobulin Light Chain AL Amyloidosis
2024 P. Lopedote, B. Evans, A. Marchetti, T. Chen, M. Moscvin, S. Boullt, N. Bolli, G. Bianchi
TENT5C/FAM46C modulation in vivo reveals a trade-off between antibody secretion and tumor growth in multiple myeloma
2024 M. Resnati, S. Pennacchio, L. Viviani, T. Perini, M. Materozzi, U. Orfanelli, J. Bordini, R. Molteni, M. Nuvolone, M. Da Vià, F. Lazzaroni, N. Bolli, S. Cenci, E. Milan
Genomic and immune determinants of resistance to daratumumab-based therapy in relapsed refractory multiple myeloma
2024 B. Ziccheddu, C. Giannotta, M. D'Agostino, G. Bertuglia, E. Saraci, S. Oliva, E. Genuardi, M. Papadimitriou, B. Diamond, P. Corradini, D. Coffey, O. Landgren, N. Bolli, B. Bruno, M. Boccadoro, M. Massaia, F. Maura, A. Larocca
Genomic Classification and Individualized Prognosis in Multiple Myeloma
2024 F. Maura, A.R. Rajanna, B. Ziccheddu, A.M. Poos, A. Derkach, K. Maclachlan, M. Durante, B. Diamond, M. Papadimitriou, F. Davies, E.M. Boyle, B. Walker, M. Hultcrantz, A. Silva, O. Hampton, J.K. Teer, E.M. Siegel, N. Bolli, G.H. Jackson, M. Kaiser, C. Pawlyn, G. Cook, D. Kazandjian, C. Stein, M. Chesi, L. Bergsagel, E.K. Mai, H. Goldschmidt, K.C. Weisel, R. Fenk, M.S. Raab, F. Van Rhee, S. Usmani, K.H. Shain, N. Weinhold, G. Morgan, O. Landgren
The Potential of JAG Ligands as Therapeutic Targets and Predictive Biomarkers in Multiple Myeloma
2023 N. Platonova, E. Lazzari, M. Colombo, M. Falleni, D. Tosi, D. Giannandrea, V. Citro, L. Casati, D. Ronchetti, N. Bolli, A. Neri, F. Torricelli, L.A. Crews, C.H.M. Jamieson, R. Chiaramonte
Single-Nucleotide Variants and Epimutations Induce Proteasome Inhibitor Resistance in Multiple Myeloma
2023 L. Haertle, S. Barrio, U. Munawar, S. Han, X. Zhou, M. Simicek, C. Vogt, M. Truger, R.A. Fernandez, M. Steinhardt, J. Weingart, R. Snaurova, S. Nerreter, E. Teufel, A. Garitano-Trojaola, M. Da Via, Y. Ruiz-Heredia, A. Rosenwald, N. Bolli, R. Hajek, P. Raab, M.S. Raab, N. Weinhold, C. Haferlach, T. Haaf, J. Martinez-Lopez, H. Einsele, L. Rasche, K.M. Kortüm
Unraveling the Neurological Complexity of Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Protein, and Skin Changes Syndrome: A Report of a Challenging Case of a Young Woman and Cutting-Edge Advancements in the Field
2023 G. Furciniti, G. Casalino, F.M. Lo Russo, N. Bolli, M. Meneri, G.P. Comi, S.P. Corti, D. Velardo
Pathological and genomic features of myeloproliferative neoplasms associated with splanchnic vein thrombosis in a single-center cohort
2023 D. Cattaneo, C. Bucelli, A. Marchetti, M. Lionetti, E. Fermo, V. Bellani, C. De Magistris, A. Maeda, A. Marella, M. Primignani, D. Consonni, U. Gianelli, A. Neri, L. Baldini, N. Bolli, A. Iurlo
Real-World Validation of Molecular International Prognostic Scoring System for Myelodysplastic Syndromes
2023 E. Sauta, M. Robin, M. Bersanelli, E. Travaglino, M. Meggendorfer, L. Zhao, J.C. Caballero Berrocal, C. Sala, G. Maggioni, M. Bernardi, C. Di Grazia, L. Vago, G. Rivoli, L. Borin, S. D'Amico, C.A. Tentori, M. Ubezio, A. Campagna, A. Russo, D. Mannina, L. Lanino, P. Chiusolo, L. Giaccone, M.T. Voso, M. Riva, E.N. Oliva, M. Zampini, E. Riva, O. Nibourel, M. Bicchieri, N. Bolli, A. Rambaldi, F. Passamonti, V. Savevski, A. Santoro, U. Germing, S. Kordasti, V. Santini, M. Diez-Campelo, G. Sanz, F. Sole, W. Kern, U. Platzbecker, L. Ades, P. Fenaux, T. Haferlach, G. Castellani, M.G. Della Porta
Mutations in the alternative complement pathway in multiple myeloma patients with carfilzomib-induced thrombotic microangiopathy
2023 M. Moscvin, C.I. Liacos, T. Chen, F. Theodorakakou, D. Fotiou, S. Hossain, S. Rowell, H. Leblebjian, E. Regan, P. Czarnecki, F. Bagnoli, N. Bolli, P. Richardson, H.G. Rennke, M.A. Dimopoulos, E. Kastritis, G. Bianchi
Activation of long non-coding RNA NEAT1 leads to survival advantage of multiple myeloma cells by supporting a positive regulatory loop with DNA repair proteins
2023 E. Taiana, C. Bandini, V.K. Favasuli, D. Ronchetti, I. Silvestris, N. Puccio, K. Todoerti, S. Erratico, D. Giannandrea, N. Bolli, N. Amodio, A. Ciarrocchi, R. Chiaramonte, Y. Torrente, R. Piva, A. Neri
Tracking the evolution of therapy-related myeloid neoplasms using chemotherapy signatures
2023 B. Diamond, B. Ziccheddu, K. Maclachlan, J. Taylor, E. Boyle, J.A. Ossa, J. Jahn, M. Affer, T.M. Totiger, D. Coffey, N. Chandhok, J. Watts, L. Cimmino, S.X. Lu, N. Bolli, K. Bolton, H. Landau, J.H. Park, K. Ganesh, A. Mcpherson, M.A. Sekeres, A. Lesokhin, D.J. Chung, Y. Zhang, C. Ho, M. Roshal, J. Tyner, S. Nimer, E. Papaemmanuil, S. Usmani, G. Morgan, O. Landgren, F. Maura
DIS3 depletion in multiple myeloma causes extensive perturbation in cell cycle progression and centrosome amplification
2023 V.K. Favasuli, D. Ronchetti, I. Silvestris, N. Puccio, G. Fabbiano, V. Traini, K. Todoerti, S. Erratico, A. Ciarrocchi, V. Fragliasso, D. Giannandrea, F. Tumiatti, R. Chiaramonte, Y. Torrente, P. Finelli, E. Morelli, N.C. Munshi, N. Bolli, A. Neri, E. Taìana
Expression levels of NONO, a nuclear protein primarily involved in paraspeckles function, are associated with several deregulated molecular pathways and poor clinical outcome in multiple myeloma
2022 D. Ronchetti, V.K. Favasuli, I. Silvestris, K. Todoerti, F. Torricelli, N. Bolli, A. Ciarrocchi, E. Taiana, A. Neri